HIRONIC, The Republic of Korea - Komachine Supplier Profile and Product List

- HIRONIC Co., Ltd. is a specialized manufacturer of aesthetic medical devices, established in 2007, focusing on the development and sale of medical aesthetic devices for clinics, personal beauty devices, and cosmetics. The company's management philosophy centers on creating beauty and healthy value for humanity, concentrating on developing differentiated products that offer new value to customers rather than merely improving existing competitor products. It leads aesthetic medicine trends with advanced medical aesthetic devices utilizing technologies such as High-Intensity Focused Ultrasound (HIFU), Radiofrequency (RF), and Cryo Fat Reduction. HIRONIC is actively expanding into global markets, including Asia, Europe, South America, and North America, aiming to become a leading global enterprise.HIRONIC Co., Ltd. is a specialized manufacturer of aesthetic medical devices, established in 2007, focusing on the development and sale of medical aesthetic devices for clinics, personal beauty devices, and cosmetics. The company's management philosophy centers on creating beauty and healthy value for humanity, concentrating on developing differentiated products that offer new value to customers rather than merely improving existing competitor products. It leads aesthetic medicine trends with advanced medical aesthetic devices utilizing technologies such as High-Intensity Focused Ultrasound (HIFU), Radiofrequency (RF), and Cryo Fat Reduction. HIRONIC is actively expanding into global markets, including Asia, Europe, South America, and North America, aiming to become a leading global enterprise.
- Doublo™: A skin lifting and wrinkle improvement device utilizing HIFU technology, developed as the first in Korea and second globally. Doublo-s™ is an upgraded version with reduced cost by removing the diagnostic ultrasound feature. Doublo Gold significantly improves treatment speed, reducing 300 shots to an average of 8 minutes.Doublo™: A skin lifting and wrinkle improvement device utilizing HIFU technology, developed as the first in Korea and second globally. Doublo-s™ is an upgraded version with reduced cost by removing the diagnostic ultrasound feature. Doublo Gold significantly improves treatment speed, reducing 300 shots to an average of 8 minutes.
- New Doublo 2.0™ / V-RO ADVANCE: A hybrid lifting complex device characterized by the combination of HIFU and RF energy sources. It incorporates Multi-Pulse and Multi-Frequency technologies, enabling three types of treatments—HIFU, RF, and Micro Needle—with a single device. It features two safety sensors, three handpieces, and 14 cartridge types for personalized treatments.New Doublo 2.0™ / V-RO ADVANCE: A hybrid lifting complex device characterized by the combination of HIFU and RF energy sources. It incorporates Multi-Pulse and Multi-Frequency technologies, enabling three types of treatments—HIFU, RF, and Micro Needle—with a single device. It features two safety sensors, three handpieces, and 14 cartridge types for personalized treatments.
- MICOOL™ and MICOOL-S™: Devices for non-invasive fat reduction using Cryo Fat Reduction technology, selectively eliminating fat cells. It employs strong negative pressure to draw in the fat layer and uses cooling energy to alleviate pain and swelling. The product offers superior cost competitiveness compared to competitors.MICOOL™ and MICOOL-S™: Devices for non-invasive fat reduction using Cryo Fat Reduction technology, selectively eliminating fat cells. It employs strong negative pressure to draw in the fat layer and uses cooling energy to alleviate pain and swelling. The product offers superior cost competitiveness compared to competitors.
- Ultra Vera™: A HIFU-based skin lifting device that achieves eyebrow lifting through tissue coagulation and is the world's first HIFU system for vaginal tightening and rejuvenation. Its advanced technology delivers energy to targeted depths without damaging the skin surface.Ultra Vera™: A HIFU-based skin lifting device that achieves eyebrow lifting through tissue coagulation and is the world's first HIFU system for vaginal tightening and rejuvenation. Its advanced technology delivers energy to targeted depths without damaging the skin surface.
- SYNERJET™ and SYNERJET PRO™: Needle-free energy devices that support skin care through uniform spraying technology and precise pressure control. The international model, SYNERJET PRO™, is a medical device combining micro-jetting, electroporation, and plasma technologies for precise drug delivery.SYNERJET™ and SYNERJET PRO™: Needle-free energy devices that support skin care through uniform spraying technology and precise pressure control. The international model, SYNERJET PRO™, is a medical device combining micro-jetting, electroporation, and plasma technologies for precise drug delivery.
- MIGLOW™: A non-invasive microwave device based on 2.45GHz Ultra High Frequency (UHF) technology, targeting the body contouring market. It incorporates skin contact cooling and electromagnetic wave shielding technologies to ensure the safety of both the patient and the practitioner.MIGLOW™: A non-invasive microwave device based on 2.45GHz Ultra High Frequency (UHF) technology, targeting the body contouring market. It incorporates skin contact cooling and electromagnetic wave shielding technologies to ensure the safety of both the patient and the practitioner.
- PICOHI™: A pico-second laser device that achieves stable 300ps Pulse Duration.PICOHI™: A pico-second laser device that achieves stable 300ps Pulse Duration.
- SILKRO™ / Gentlo: An RF microneedle-based general electrosurgical unit that uses radiofrequency (RF) energy for tissue coagulation and pain relief. The addition of a Plasma Stream (PS) handpiece is expected to create synergistic effects and boost consumable sales.SILKRO™ / Gentlo: An RF microneedle-based general electrosurgical unit that uses radiofrequency (RF) energy for tissue coagulation and pain relief. The addition of a Plasma Stream (PS) handpiece is expected to create synergistic effects and boost consumable sales.
- EASYMO GRAFT: A device for Follicular Unit Extraction (FUE) hair transplantation.EASYMO GRAFT: A device for Follicular Unit Extraction (FUE) hair transplantation.
- Proprietary Technology and Patent Competitiveness: A technology leader, being the first in Korea and second globally to develop the HIFU lifting device 'Doublo'. As of March 2024, the company holds approximately 407 intellectual property rights, including patents, utility models, trademarks, and designs, reinforcing its technological edge.Proprietary Technology and Patent Competitiveness: A technology leader, being the first in Korea and second globally to develop the HIFU lifting device 'Doublo'. As of March 2024, the company holds approximately 407 intellectual property rights, including patents, utility models, trademarks, and designs, reinforcing its technological edge.
- Diversified Technology Portfolio: Establishment of a full lineup of energy-based aesthetic medical devices, including HIFU, RF, Cryo fat reduction, Laser, Plasma, Microjet, and UHF. The capability to develop multi-functional devices that offer various treatments with a single machine, addressing diverse market demands.Diversified Technology Portfolio: Establishment of a full lineup of energy-based aesthetic medical devices, including HIFU, RF, Cryo fat reduction, Laser, Plasma, Microjet, and UHF. The capability to develop multi-functional devices that offer various treatments with a single machine, addressing diverse market demands.
- Global Market Expansion and Certification Acquisition: Acquisition of key international medical device certifications such as Brazil's ANVISA, Europe's CE MDD, China's CQC, and the US FDA 510(k), accelerating entry into overseas markets. Exports accounted for 62.6% of total sales in 2023, with a strategy to diversify revenue across regions including South America, Europe, and Asia.Global Market Expansion and Certification Acquisition: Acquisition of key international medical device certifications such as Brazil's ANVISA, Europe's CE MDD, China's CQC, and the US FDA 510(k), accelerating entry into overseas markets. Exports accounted for 62.6% of total sales in 2023, with a strategy to diversify revenue across regions including South America, Europe, and Asia.
- Focus on Differentiated Product Development and Customer Value: A management philosophy centered on creating differentiated products that provide new value to customers, rather than merely outperforming competitors. Continuous technological innovation for safe and effective treatments, along with user-friendly product design.Focus on Differentiated Product Development and Customer Value: A management philosophy centered on creating differentiated products that provide new value to customers, rather than merely outperforming competitors. Continuous technological innovation for safe and effective treatments, along with user-friendly product design.
- Stable Revenue Model Based on Consumables: Generation of continuous revenue through the sale of consumables such as Doublo cartridges and MICOOL gel pads/liners. Anticipation of operating leverage effects due to increasing consumable sales.Stable Revenue Model Based on Consumables: Generation of continuous revenue through the sale of consumables such as Doublo cartridges and MICOOL gel pads/liners. Anticipation of operating leverage effects due to increasing consumable sales.
- Future Competitiveness through AI Technology Integration: Strategic collaboration with AI specialist Raonpeople to integrate artificial intelligence into medical aesthetic devices and automate production processes. Plans for incorporating AI-based skin diagnostic services and leveraging clinical data for additional services.Future Competitiveness through AI Technology Integration: Strategic collaboration with AI specialist Raonpeople to integrate artificial intelligence into medical aesthetic devices and automate production processes. Plans for incorporating AI-based skin diagnostic services and leveraging clinical data for additional services.
- DermatologyDermatology
- Plastic SurgeryPlastic Surgery
- Obesity ClinicsObesity Clinics
- Gynecology (Vaginal Tightening)Gynecology (Vaginal Tightening)
- Hair Transplantation ClinicsHair Transplantation Clinics
- Home Beauty Care MarketHome Beauty Care Market
- China, India, Vietnam, Indonesia, Japan, Middle EastChina, India, Vietnam, Indonesia, Japan, Middle East
- European Union (EU) Member States, RussiaEuropean Union (EU) Member States, Russia
- United StatesUnited States
- Oceania (selected markets)Oceania (selected markets)
- Brazil, PeruBrazil, Peru
- Holds approximately 407 intellectual property rights, including domestic and international patents, utility models, trademarks, and designs.Holds approximately 407 intellectual property rights, including domestic and international patents, utility models, trademarks, and designs.
- Won a patent invalidation trial against Guided Therapy Systems in the USA.Won a patent invalidation trial against Guided Therapy Systems in the USA.
- Reached a non-assertion agreement with Ulthera Inc. regarding HIFU medical device patents, mutually recognizing patent rights.Reached a non-assertion agreement with Ulthera Inc. regarding HIFU medical device patents, mutually recognizing patent rights.
- Obtained European Medical Device Directive (CE MDD) certification for Doublo and Doublo-S.Obtained European Medical Device Directive (CE MDD) certification for Doublo and Doublo-S.
- Received Brazilian Health Regulatory Agency (ANVISA) certification for New Doublo 2.0 (V-RO ADVANCE).Received Brazilian Health Regulatory Agency (ANVISA) certification for New Doublo 2.0 (V-RO ADVANCE).
- Achieved China Quality Certification (CQC) for Doublo Gold.Achieved China Quality Certification (CQC) for Doublo Gold.
- Secured import approval from the Central Drugs Standard Control Organization (CDSCO) in India for Doublo Gold, Ultra Vera, and MICOOL S.Secured import approval from the Central Drugs Standard Control Organization (CDSCO) in India for Doublo Gold, Ultra Vera, and MICOOL S.
- Obtained Brazilian ANVISA certification for the general electrosurgical unit Gentlo (SILKRO™).Obtained Brazilian ANVISA certification for the general electrosurgical unit Gentlo (SILKRO™).
- Received US Food and Drug Administration (FDA) 510(k) clearance for the general electrosurgical medical device SILKRO™.Received US Food and Drug Administration (FDA) 510(k) clearance for the general electrosurgical medical device SILKRO™.
- Awarded the Prime Minister's Award in the Technology Innovation category at the 14th SME Technology Innovation Daejeon (for Doublo) in 2013.Awarded the Prime Minister's Award in the Technology Innovation category at the 14th SME Technology Innovation Daejeon (for Doublo) in 2013.
- Received the Presidential Award in the Technology Innovation Enterprise category at the 15th SME Technology Innovation Daejeon (for Doublo and MICOOL) in 2014.Received the Presidential Award in the Technology Innovation Enterprise category at the 15th SME Technology Innovation Daejeon (for Doublo and MICOOL) in 2014.
- Awarded the 'Ten Million Dollar Export Tower' in 2015.Awarded the 'Ten Million Dollar Export Tower' in 2015.
- Doublo designated as a 'World Class Product' in 2016.Doublo designated as a 'World Class Product' in 2016.